Thursday March 11, 2027

Non-CME Program

10:00 am – 11:00 am: Brunch with ILD Presentation Location: Portola Hotel, The Club Room

Topic: TBD
Speaker: TBD

CME Program

Location: Monterey Convention Center (Floor 2), Steinbeck 1 & 2

Interstitial Lung Disease Clinical Classification and Approach to Antifibrotic Therapy

11:00 am – 11:45 am – Update on ILD classification (2025 ATS/ERS update) and Community integration

• Kerri Johannson, MD MPH (University of Calgary) This speaker will discuss the 2025 update of the international multidisciplinary classification of the interstitial pneumonias led by the ATS/ERS, as well as resources for the community physician in making the correct ILD diagnosis

11:45 pm – 12:05 pm Biomarkers, genomics, and precision medicine in ILD

• Paul Wolters, MD (UC San Francisco) This speaker will discuss advances in biomarkers and genomics in interstitial lung
disease, and will highlight how precision medicine will impact the future of care

12:05 am – 12:25 pm - Landscape of current therapy and emerging trials in progressive fibrosing ILD

• Toby Maher, MD PhD (University of Southern California) This speaker will discuss the current landscape of pharmacologic
therapy in the prevention of progression of pulmonary fibrosis, as well as novel agents in drug development

12:25 pm – 12:45 pm - Approach to interstitial lung abnormalities

• Gabrielle Liu, MD MS (UC Davis) This speaker will discuss the way to approach interstitial lung abnormalities, how to
differentiate interstitial lung abnormalities from disease, and how to follow patients with interstitial lung abnormalities

12:45 pm – 1:00 pm - Pro: Patients with IPF/PPF should be on dual combination antifibrotics

• Hayley Barnes, MBBS PhD (UC San Francisco) This speaker will argue in favor of dual combination therapy in IPF/PPF

1:00 pm – 1:15 pm - Con: Patients with IPF/PPF should NOT be on dual combination antifibrotics

• Erica Farrand, MD (UC San Francisco) This speaker will argue against dual combination therapy in IPF/PPF

1:15 pm-1:30 pm – Question and Answer

1:30 pm -2:30 pm – Lunch Location: Portola Hotel, The Club Room

Imaging, Pathology, and Subgroups of Interstitial Lung Disease

2:30 pm – 2:50 pm – CT findings in ILD and incorporation of AI in interpretation

• Speaker TBD – This speaker will discuss ways to differentiate the imaging findings in interstitial lung disease and how artificial intelligence can be used to assist in making the diagnosis

2:50 pm – 3:10 pm – What the pathologist looks for in making the diagnosis

• Kirk Jones, MD (UC San Francisco) This speaker will discuss what the pathologist is looking for under the microscope to differentiate various forms of interstitial lung disease and when the pathologic diagnosis may be helpful

3:10 pm – 3:30 pm – Complexities of care in ILD from Sarcoidosis

• Kenneth Knox, MD (University of Arizona – Phoenix) This speaker will discuss the unique clinical entity of sarcoidosis, how to make the diagnosis, the non-pulmonary systemic manifestations, and when to consider immunosuppressive therapy

3:30 pm – 3:50 pm – Complexities of care in ILD from Chronic Hypersensitivity Pneumonitis

• Sachin Chaudhary, MD (University of Arizona – Tucson) This speaker will discuss the unique clinical entity of chronic hypersensitivity pneumonitis, which antigens are most important to consider, and how clinical management differs from IPF

3:30 pm – 3:50 pm – Complexities of care in ILD from Scleroderma

• Elizabeth Volkmann, MD MS (UC Los Angeles) This speaker will discuss Scleroderma related interstitial lung disease, other important non-parenchymal manifestations to consider in Scleroderma, and how clinical management differs from IPF

4:10 pm - 4:25 pm – Question and Answer

4:25 pm – 5:05 pm Coffee Break and refreshments with exhibitors: Location: Portola Hotel, De Anza Foyer

Comprehensive Care of the patient with Interstitial Lung Disease

5:05 pm – 5:25 pm Pulmonary Hypertension in ILD

• Rajan Saggar, MD (UC Los Angeles) This speaker will discuss when patients should be screened for pulmonary hypertension in the context of ILD, how treatment differs in this population, and emerging therapies under investigation

5:25 pm – 5:45 pm Comprehensive ILD care: pulmonary rehabilitation, transplant referral, and palliative care

• Kaïssa de Boer, MD (Stanford) This speaker will discuss the comprehensive ancillary services required to care for the patient with interstitial lung disease, when to make referrals for rehabilitation, transplantation, and palliation

5:45 pm – 6:30 pm Multidisciplinary ILD discussion with cases

• Derrick Cleland, MD (Cedars-Sinai) – In this multidisciplinary case conference a trainee will present three complex cases to a multidisciplinary team of providers including a radiologist, a pathologist, and interstitial lung disease experts

6:30 pm – 6:45 pm - Question and Answer

Non-CME Program

Conference Meet and Greet Welcome Reception and Presentation

7:00 pm - 8:30 pm: Location: Portola Hotel, The Club Room, Sponsored by: TBD Topic: TBD

 

Friday March 12, 2027

Non-CME Program

7:00 am – 7:45 am: Breakfast with presentation Location: Portola Hotel, The Club Room, Sponsored by: TBD

Topic: TBD
Speakers: TBD

CME Program

Update on Rare Lung Diseases

Location: Monterey Convention Center (Floor 2), Steinbeck 1 & 2

8:00 am – 8:15 am – Introduction and Welcome

8:15 am – 9:00 am – The story of Pulmonary Alveolar Proteinosis

• Tisha Wang, MD (University of Washington) - This speaker will discuss the story of Pulmonary Alveolar Proteinosis, how the diagnosis is made, treatment approaches for the patient with advanced disease, and advances in pharmacotherapy

9:00 am – 9:25 am Evaluation and management of cystic lung diseases

• Bernie Sunwoo, MBBS (UC San Diego) - This speaker will discuss the rare cystic lung diseases Lymphangioleiomyomatosis, Birt-Hogg-Dubé Syndrome, and Lymphoid Interstitial Pneumonia, how to differentiate them, and management principles

9:25 am – 9:50 am Portopulmonary Hypertension, Hepatopulmonary syndrome and Hereditary Hemorrhagic Telangiectasia

• Arun Jose, MD MS (University of Cincinnati) - This speaker will discuss Portopulmonary Hypertension, Hepatopulmonary Syndrome, and Hereditary Hemorrhagic Telangectasia, how to make the diagnosis, and complexities of care

9:50 am -10:05 am Question and Answer

10:05 am -10:45 am - Coffee Break and Refreshments with exhibitors Location: Portola Hotel, De Anza Ballroom

Advanced Concepts in Mechanical Ventilation

10:45 am – 11:10 am Advances in artificial intelligence integration into mechanical ventilation

• Preeti Gupta, MD MPH (UC San Diego) This speaker will discuss how artificial intelligence is incorporated into mechanical
ventilation, how adaptive support modes work, and how artificial intelligence may change future ventilation strategies

11:10 am – 11:25 am Pro: Smart Vent Modes are the best for our patients

• Rob Bautista, RRT (UC San Francisco) This speaker will argue that smart vent modes are SOC for critically ill patients

11:25 am – 11:40 am Con: Smart Vent Modes are NOT the best for our patients

• Marc Bomactao, RRT (UC Davis) This speaker will argue in against smart vent modes as being SOC for critically ill patients

11:40 am – 12:05 pm – Advances in automation for management of sleep disordered breathing

• Saif Mashaqi, MD (University of Arizona – Tucson) This speaker will discuss advances automation for the management of
sleep apnea and other sleep disordered breathing

12:05 pm – 12:20 pm Q&A

12:20 pm – 1:00 pm – Awards Ceremony

1:00 pm – 2:00 pm Lunch Location: Portola Hotel, De Anza Ballroom

Hands On Session:

Location: TBD - Monterey Convention Center (Floor 2), Steinbeck 3 or Portola Hotel, Portola Room

2:00 pm – 3:00 pm:

AI imaging for ILD Speaker TBD

Smart Vent Modes Speaker TBD;

Organ Preservation Devices Speaker TBD;

Airway Stents for Post-Transplant Stenosis Speaker TBD

3:00 pm – 3:20 pm: Coffee Break and Refreshments with exhibitors Location: Portola Hotel, De Anza Ballroom

What the non-lung transplant pulmonologists needs to know about lung transplantation

3:30 pm – 3:55 pm - Timing and indications for referral

• Lorriana Leard, MD (UC San Francisco) This speaker will discuss the ISHLTConsensus Document on the Selection of Lung Transplant Recipients in COPD, PAH, CF, and ILD, as well as what has changed in selection since publication

3:55 pm – 4:20 pm - Emergent evaluation for hospitalized/critically ill patient with advanced lung disease

• Laveena Chhatwani, MD MSc (Stanford) This speaker will discuss the considerations when doing an inpatient evaluation for the critically ill and hospitalized patient with advanced lung disease

4:20 pm – 4:45 pm Donor management and advances in organ preservation

• Pedro Catarino, MD (Cedars-Sinai) – This speaker will discuss how donors should be optimized to ensure adequacy of donation, and how organ preservation has advanced through ex-vivo lung perfusion and cold preservation

4:45 pm – 5:10 pm Post transplant care and outcomes

• David Sayah, MD PhD (UC Los Angeles) This speaker will discuss how post transplant care has improved over time in the outcomes that are meaningful to patients, and the major drug interactions non-transplant providers need to be aware of

5:10 pm – 5:25 pm: Question and Answer

Non-CME Program

Women in Pulmonary, Critical Care, and Sleep Medicine (NON-CME)

5:30 pm – 7:00 pm Food and beverages will be servedFood and beverages will be served - Location: Portola Hotel, Bonsai Ballroom

Forum Leaders: TBD

Saturday March 13, 2027

Non-CME Program

7:00 am – 7:45 am: Breakfast with presentation Location: Portola Hotel, Bonsai Ballroom Sponsored by: TBD

Update on Pulmonary Embolism

CME Program

Location: Monterey Convention Center (Floor 2), Steinbeck 1 & 2

8:00 am – 8:15 am – Introduction and Welcome

8:15 am – 9:00 am – Keynote: Update on the 2026 Multi Society PE Guidelines

• Rachel Rosovsky, MD MPH (Mass General Brigham)- This speaker will discuss the new AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN guidelines on the management of acute pulmonary embolism in adults

9:00 am – 9:15 am – Pro - Percutaneous thrombectomy is standard of care for acute pulmonary embolism

• Speaker TBD - This speaker will argue in favor of percutaneous thrombectomy as standard of care for acute PE

9:15 am – 9:30 am – Con - Percutaneous thrombectomy is NOT standard of care for acute pulmonary embolism

• Janine Vintch, MD (Harbor-UCLA) This speaker will argue against percutaneous thrombectomy as SOC for acute PE

9:30 am – 9:55 am – After the pulmonary embolism: post-acute follow-up

• Timothy Morris, MD (UC San Diego) This speaker will describe optimal follow up after a pulmonary embolism, the model of a post pulmonary embolism clinic, and when to consider testing for chronic thromboembolic pulmonary hypertension

9:55-10:10 am Question and Answer

10:10 am – 10:50 am: Coffee Break and Refreshments with exhibitors Location: Portola Hotel, De Anza Ballroom

Pregnancy in Pulmonary and Critical Care Medicine

10:50 am – 11:15 am – Physiologic changes in respiration during pregnancy

• Brad Sanville, MD (UC Davis) This speaker will discuss the physiologic changes that occur in pregnancy relevant to
pulmonary physiology and exercise physiology

11:15 am – 11:40 am – Airways disease in pregnancy

• Jeffrey Barry, MD MPH (UC San Diego) - This speaker will discuss the worsening of control of airways disease that is
commonly seen in pregnancy, how to manage exacerbations in pregnancy, and which therapeutic options to avoid

11:40 am – 12:15 pm – Pulmonary Arterial Hypertension in pregnancy

• Naomi Habib, MD (Norton Thoracic) This speaker will discuss the how pregnancy impacts pulmonary hemodynamics,
which medications are teratogenic in pregnancy, and how to handle the pregnant patient with PAH and CTEPH

12:15 pm – 12:40 pm - Obstetric considerations in the pregnant patient with critical illness and pulmonary disease

• Mariam Naqvi, MD (Cedars-Sinai) This speaker will discuss the obstetric considerations for the pregnant patient with
pulmonary disease and critical illness, when to consider early delivery, and what to monitor in the post-partum period

12:40 pm – 12:55 pm – Question and Answer

12:55 pm – 2:00 pm Lunch Location: Portola Hotel, De Anza Ballroom

Hands-On Session:

1:20 pm – 2:20 pm:

Location: TBD - Monterey Convention Center (Floor 2), Steinbeck 3 or Portola Hotel, Portola Room

Pulmonary embolism retrieval devices Speaker TBD

CPET machine Speaker TBD

Personal Protective Equipment Speaker TBD

Intubation Skills Speaker TBD

2:20 pm – 2:45 pm: Coffee break with exhibitors Location: De Anza Ballroom

Infectious Diseases in the Intensive Care Unit

3:30 pm – 3:55 pm – Fungal infections in the Intensive Care Unit

• Speaker TBD - This speaker will discuss approaches to therapy for emerging fungal infections providers will face in the intensive care unit including Mucor, Candida Aureus/Krusei, Aspergillus, and Coccidioides

3:55 pm – 4:20 pm – Viral Hemorrhagic Fevers in the Intensive Care Unit

• Michele Maison-Fomotar, MD MSc (UCSF-Fresno) - This speaker will discuss the emerging viral hemorrhagic fevers that providers may face in the intensive care unit including Ebola, Dengue, Yellow Fever, and Hantavirus

4:20 pm – 4:45 pm – Meningitis and encephalitis in the Intensive Care Unit

• Kassi Kronfeld, MD (Harbor-UCLA) This speaker will discuss the approach to diagnosis of meningitis and encephalitis in the intensive care unit, how to differentiate various diseases, and which treatments are mandatory in which patients

4:45 pm – 5:10 pm – Emerging risks for the next pandemic

• Speaker TBD- This speaker will discuss current state of various respiratory viruses around the world, which ones pose risks for the next global pandemic, and the current state of preparedness

5:10 pm – 5:25 pm – Question and Answer

Non-CME Program

Trainee Poster Competition

5:30 pm – 7:30 pm: Location: Portola Hotel, De Anza Ballroom, Sponsored by: TBD – Food and beverages will be served